2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

被引：770

作者：

Braun, J. ^{[1
,2
]}

van den Berg, R. ^{[3
]}

Baraliakos, X. ^{[1
]}

Boehm, H. ^{[4
]}

Burgos-Vargas, R. ^{[5
,6
]}

Collantes-Estevez, E. ^{[7
]}

Dagfinrud, H. ^{[8
,9
]}

Dijkmans, B. ^{[10
]}

Dougados, M. ^{[11
]}

Emery, P. ^{[12
]}

Geher, P. ^{[13
]}

Hammoudeh, M. ^{[14
]}

Inman, R. D. ^{[15
]}

Jongkees, M.

Khan, M. A. ^{[16
]}

Kiltz, U. ^{[1
]}

Kvien, T. K. ^{[8
]}

Leirisalo-Repo, M. ^{[17
]}

Maksymowych, W. P. ^{[18
]}

Olivieri, I. ^{[19
]}

Pavelka, K. ^{[20
,21
]}

Sieper, J. ^{[22
]}

Stanislawska-Biernat, E. ^{[23
]}

Wendling, D. ^{[24
]}

Ozgocmen, S. ^{[25
]}

van Drogen, C.

van Royen, B. J. ^{[26
]}

van der Heijde, D. ^{[3
]}

机构：

[1] Rheumazentrum Ruhrgebiet, Landgrafenstr 15, D-44652 Herne, Germany

[2] Ruhr Univ Bochum, Bochum, Germany

[3] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands

[4] Wirbelsaulenzentrum, Bad Berka, Germany

[5] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Dept Rheumatol, Mexico City 04510, DF, Mexico

[6] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico

[7] Univ Cordoba, IMIBC, E-14071 Cordoba, Spain

[8] Univ Oslo, Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway

[9] Univ Oslo, Oslo, Norway

[10] Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands

[11] Descartes Univ Paris, Cochin Hosp, Rheumatol Dept B, Paris, France

[12] Univ Leeds, Sect Musculoskeletal Dis, Leeds, W Yorkshire, England

[13] Univ Budapest, Budapest, Hungary

[14] Hamad Med Corp, Doha, Qatar

[15] Univ Toronto, Toronto, ON, Canada

[16] Case Western Reserve Univ, Cleveland, OH 44106 USA

[17] Univ Helsinki, Cent Hosp, Dept Med, Div Rheumatol, Helsinki, Finland

[18] Univ Alberta, Edmonton, AB, Canada

[19] San Carlo Hosp, Potenza, Italy

[20] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic

[21] Charles Univ Prague, Clin Rheumatol, Prague, Czech Republic

[22] Charite, Dept Gastroenterol & Rheumatol, D-13353 Berlin, Germany

[23] Inst Rheumatol, Warsaw, Poland

[24] Univ Besancon, F-25030 Besancon, France

[25] Erciyes Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Kayseri, Turkey

[26] Vrije Univ Amsterdam Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2011年 / 70卷 / 06期

关键词：

ANTITUMOR-NECROSIS-FACTOR; SOCIETY CLASSIFICATION CRITERIA; DECREASED CLINICAL-RESPONSE; ASAS CONSENSUS STATEMENT; INFLAMMATORY BACK-PAIN; ANTI-TNF THERAPY; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; RADIOGRAPHIC PROGRESSION; EULAR RECOMMENDATIONS;

D O I：

10.1136/ard.2011.151027

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

This first up date of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiotherapists in a meeting in February 2010. Each original bullet point was discussed in de tail and reworded if necessary. Decisions on new recommendations were made - if necessary after voting. The strength of the recommendations (SOR) was scored on an 11-point numerical rating scale after the meeting by email. These recommendations apply to patients of all ages that fulfill the modified NY criteria for AS, independent of extra-articular manifestations, and they take into account all drug and non-drug interventions related to AS. Four overarching principles were introduced, implying that one bullet has been moved to this section. There are now 11 bullet points including 2 new ones, one related to extra-articular manifestations and one to changes in the disease course. With a mean score of 9.1 (range 8-10) the SOR was generally very good.

引用

页码：896 / 904

页数：9

共 96 条

[1]

Hip involvement in ankylosing spondylitis What is the verdict? [J].

Baraliakos, Xenofon ;

Braun, Juergen .

RHEUMATOLOGY, 2010, 49 (01) :3-4

[2]

Clinical and Imaging Efficacy of Infliximab in HLA-B27-Positive Patients With Magnetic Resonance Imaging-Determined Early Sacroiliitis [J].

Barkham, Nick ;

Keen, Helen I. ;

Coates, Laura C. ;

O'Connor, Philip ;

Hensor, Elizabeth ;

Fraser, Alexander D. ;

Cawkwell, Lorna S. ;

Bennett, Alexander ;

McGonagle, Dennis ;

Emery, Paul .

ARTHRITIS AND RHEUMATISM, 2009, 60 (04) :946-954

[3]

Bennett AN, 2008, ARTHRITIS RHEUM, V58, pS609

[4]

Primary cementless total hip arthroplasty for bony ankylosis in patients with ankylosing spondylitis [J].

Bhan, Surya ;

Eachempati, Krishna Kiran ;

Malhotra, Rajesh .

JOURNAL OF ARTHROPLASTY, 2008, 23 (06) :859-866

[5]

ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health [J].

Boonen, A. ;

Braun, J. ;

Bruinsma, I. E. van der Horst ;

Huang, F. ;

Maksymowych, W. ;

Kostanjsek, N. ;

Cieza, A. ;

Stucki, G. ;

van der Heijde, D. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :102-107

[6]

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept [J].

Braun, J ;

Baraliakos, X ;

Listing, J ;

Sieper, J .

ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2447-2451

[7]

Persistent clinical efficacy and safety of anti-tumour necrosis factor a therapy with infliximab in patients with ankylosing spondylitis over 5 years:: evidence for different types of response [J].

Braun, J. ;

Baraliakos, X. ;

Listing, J. ;

Fritz, C. ;

Alten, R. ;

Burmester, G. ;

Krause, A. ;

Schewe, S. ;

Schneider, M. ;

Soerensen, H. ;

Zeidler, H. ;

Sieper, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) :340-345

[8]

Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly [J].

Braun, J. ;

McHugh, N. ;

Singh, A. ;

Wajdula, J. S. ;

Sato, R. .

RHEUMATOLOGY, 2007, 46 (06) :999-1004

[9]

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agents [J].

Braun, J. ;

Baraliakos, X. ;

Listing, J. ;

Davis, J. ;

Van der Heijde, D. ;

Haibel, H. ;

Rudwaleit, M. ;

Sieper, J. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (04) :639-647

[10]

Braun J, 2006, Z RHEUMATOL, V65, P728, DOI 10.1007/s00393-006-0119-3

← 1 2 3 4 5 6 7 8 9 10 →